Verve Therapeutics (VERV) - Cost to borrow

This company appears to have been delisted
Reason: Acquired by Lilly
Last recorded trade on: August 15, 2025
Source: https://investor.lilly.com/news-releases/news-release-details/lilly-completes-acquisition-verve-therapeutics-advance-one-time

Verve Therapeutics

VERV

#6051

Rank

C$1.36 B

Marketcap

🇺🇸 United States

Country

C$15.24

Share price

0.00%

Change (1 day)

116.24%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech 🧬 Genomics 🧬 Gene therapy

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions